Through multidisciplinary coordination, effective communication, and a robust quality improvement initiative, we'll share invaluable insights, strategies, and patient-centered approaches that redefine ovarian cancer care. Gain firsthand knowledge from our panel of experts as they reveal lessons learned and experiences from participating in this quality improvement initiative. Discover how these insights have informed practice improvements, all while exploring the innovative Ovarian Quality of Care self-assessment tool, a valuable resource for cancer programs to enhance patient outcomes and drive excellence in ovarian cancer care.

This webinar will explore critical aspects of quality care in ovarian cancer treatment, exploring the journey from process optimization to enhancing overall patient outcomes. Our panel will illuminate the intricacies of ovarian cancer care, drawing from lessons learned across both phase one and two of the quality improvement initiative, and best practices in navigating the complexities of ovarian cancer care with a focus on continuous improvement.

In this series, experts share advice on the optimal management of immune-related adverse events (irAEs). Each session covers a different class of irAE-associated immunotherapies and includes evaluation and discussion of one or more case studies.

Practical Insights on How to Improve Comprehensive Biomarker Testing in Advanced Non-Small Cell Lung Cancer

Explore opportunities to expand multidisciplinary care collaboration and coordination to improve care for patients with non-melanoma skin cancers.

T​his webinar will highlight how community cancer programs are using a new approach to optimize biomarker testing processes through the addition of a precision medicine steward.

Raise awareness among cancer programs of new treatment options for newly diagnosed patients with multiple myeloma ineligible for transplant.

This activity will provide guidance on how to develop practical biomarker testing protocols and identify appropriate therapeutics treatments for patients in all stages of mCRC.

Oncology state society leaders from the Appalachian Community Cancer Alliance share an introduction to the Alliance, their insights into the unique needs of the Appalachian region and beyond, how the Alliance is responding and how you can get involved.

This educational initiative will focus on multidisciplinary education surrounding TILs, with an emphasis on the importance of implementing clinical trials in the community setting.